The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders
Authors
Keywords
Resveratrol, Nerve growth factor, Endocannabinoid system, Brain, Rat
Journal
PSYCHOPHARMACOLOGY
Volume 233, Issue 6, Pages 1087-1096
Publisher
Springer Nature
Online
2016-01-18
DOI
10.1007/s00213-015-4188-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The journey of resveratrol from yeast to human
- (2016) Silvie Timmers et al. Aging-US
- Generic Substitution for Psychotropic Drugs
- (2016) Pierre Blier CNS SPECTRUMS
- Nerve Growth Factor: A Focus on Neuroscience and Therapy
- (2015) Luigi Aloe et al. Current Neuropharmacology
- Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial
- (2015) Sanne M. van der Made et al. PLoS One
- Antidepressant effects of resveratrol in an animal model of depression
- (2014) Laura L. Hurley et al. BEHAVIOURAL BRAIN RESEARCH
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- Understanding the anti-kindling role and its mechanism of Resveratrol in Pentylenetetrazole induced-kindling in a rat model
- (2014) Lekha Saha et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
- (2013) Joao Tomé-Carneiro et al. CURRENT PHARMACEUTICAL DESIGN
- Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: The HPA axis, BDNF expression and phosphorylation of ERK
- (2013) Zhen Wang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Implication of NGF and endocannabinoid signaling in the mechanism of action of sesamol: a multi-target natural compound with therapeutic potential
- (2013) Parichehr Hassanzadeh et al. PSYCHOPHARMACOLOGY
- Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance
- (2012) Jun Yoshino et al. Cell Metabolism
- Antidepressant-like effect of trans-resveratrol in chronic stress model: Behavioral and neurochemical evidences
- (2012) Yingcong Yu et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The CB1 Receptor-Mediated Endocannabinoid Signaling and NGF: The Novel Targets of Curcumin
- (2012) Parichehr Hassanzadeh et al. NEUROCHEMICAL RESEARCH
- Resveratrol Inhibits Inflammatory Responses via the Mammalian Target of Rapamycin Signaling Pathway in Cultured LPS-Stimulated Microglial Cells
- (2012) Lian-Mei Zhong et al. PLoS One
- Clinical trials of resveratrol
- (2011) Ketan R. Patel et al. Annals of the New York Academy of Sciences
- The novel trisubstituted pyran derivative D-142 has triple monoamine reuptake inhibitory activity and exerts potent antidepressant-like activity in rodents
- (2011) Aloke K. Dutta et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Involvement of the neurotrophin and cannabinoid systems in the mechanisms of action of neurokinin receptor antagonists
- (2011) Parichehr Hassanzadeh et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The cannabinoid receptor CB1 inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala
- (2011) Lindsey M. Dono et al. NEUROPHARMACOLOGY
- Cannabinoids and emotionality: a neuroanatomical perspective
- (2011) R.J. McLaughlin et al. NEUROSCIENCE
- Amitriptyline-Mediated Cognitive Enhancement in Aged 3×Tg Alzheimer's Disease Mice Is Associated with Neurogenesis and Neurotrophic Activity
- (2011) Wayne Chadwick et al. PLoS One
- Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system
- (2010) Ying Xu et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- 2-Adrenoceptor Blockade Accelerates the Neurogenic, Neurotrophic, and Behavioral Effects of Chronic Antidepressant Treatment
- (2010) S. U. Yanpallewar et al. JOURNAL OF NEUROSCIENCE
- Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases
- (2010) Albert Y. Sun et al. MOLECULAR NEUROBIOLOGY
- The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat
- (2010) R. Abalo et al. NEUROGASTROENTEROLOGY AND MOTILITY
- The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs
- (2010) Parichehr Hassanzadeh et al. PSYCHOPHARMACOLOGY
- CB1 Receptor Blockade Decreases Ethanol Intake and Associated Neurochemical Changes in Fawn-Hooded Rats
- (2009) Teresa FemenÃa et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Protective Effects of Resveratrol and Quercetin Against MPP+ -Induced Oxidative Stress Act by Modulating Markers of Apoptotic Death in Dopaminergic Neurons
- (2009) Julie Bournival et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Amitriptyline is a TrkA and TrkB Receptor Agonist that Promotes TrkA/TrkB Heterodimerization and Has Potent Neurotrophic Activity
- (2009) Sung-Wuk Jang et al. CHEMISTRY & BIOLOGY
- Complementary and alternative medicine in the treatment of anxiety and depression
- (2009) Gill van der Watt et al. CURRENT OPINION IN PSYCHIATRY
- Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models
- (2009) Francis Rodriguez Bambico et al. CURRENT PHARMACEUTICAL DESIGN
- Altered CB1receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine
- (2009) Antonio Rodríguez-Gaztelumendi et al. JOURNAL OF NEUROCHEMISTRY
- NGF Is Essential for Hippocampal Plasticity and Learning
- (2009) J. M. Conner et al. JOURNAL OF NEUROSCIENCE
- Resveratrol: One molecule, many targets
- (2008) Luciano Pirola et al. IUBMB LIFE
- Beneficial Effects of Resveratrol on Atherosclerosis
- (2008) Enguo Fan et al. JOURNAL OF MEDICINAL FOOD
- Combination therapy with intranasal NGF and electroacupuncture enhanced cell proliferation and survival in rats after stroke
- (2008) Songming Cheng et al. NEUROLOGICAL RESEARCH
- Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation
- (2007) Genevieve Bureau et al. JOURNAL OF NEUROSCIENCE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More